Background Multiple sclerosis (MS) is the most common cause of neurological disability in
young adults worldwide and approximately half of those affected are in Europe. The …

An increased interest in population-based registries and databases will provide more valid
epidemiological measures and observational studies conducted in well-defined study …

Multiple sclerosis (MS) is the most frequently seen demyelinating disease, with a prevalence
that varies considerably, from high levels in North America and Europe (> 100/100,000 …

BACKGROUND: The spectrum of disorders of the brain is large, covering hundreds of
disorders that are listed in either the mental or neurological disorder chapters of the …

Background: Few nationwide multiple sclerosis (MS) prevalence studies have been
published. In Scandinavia, the nationwide MS prevalence was 173/100,000 in Denmark …

The clinical features, diagnostic challenges, neuroimaging appearance, therapeutic options,
and pathobiological research progress in childhood—and adolescent—onset multiple …

Progesterone is well known as a female reproductive hormone and in particular for its role in
uterine receptivity, implantation, and the maintenance of pregnancy. However …

Background and purpose Few studies have investigated the differences in cognitive skills
between the three subtypes of multiple sclerosis (MS) and they confounded the course of the …

Myelin regeneration is a major therapeutic goal in demyelinating diseases, and the failure to
remyelinate rapidly has profound consequences for the health of axons and for brain …

Multiple sclerosis (MS) is a chronic debilitating inflammatory disease of unknown ethology
targeting the central nervous system (CNS). MS has a polysymptomatic onset and is usually …